Ghanaian Drug Producer Ernest Chemist Invests $50m in New Plant

Google+ Pinterest LinkedIn Tumblr +

Ernest Chemist, one of Ghana’s leading pharmaceutical companies is set to complete its ultramodern European Union Good Manufacturing Practice (EU GMP) standard factory by end of year.

The pharmaceutical plant which is estimated at about $50 million occupies close to 11 thousand square meters of land size with a 20 thousand square meter fully automated warehouse.

Chief Executive Officer of Ernest Chemist, Dr. Ernest Bediako said the new factory is built to meet international standards in order to attract multinational companies with regards to partnership and production outsourcing.

“It is a factory of European Union GMP standard so you need the right equipment which may be expensive,” he said

On his side, the Project Manager, Evans Essienyi said because the facility is being built on European Union GMP standards, drugs produced will be sold across the borders of Ghana. “I am happy to inform you that you’re sharing history, this project when completed will be the first of its kind in Ghana and the sub-region.”

According to him, Ernest Chemist is currently unable to take on international contracts because their current manufacturing site does not meet international standards, adding that “when the new edifice is done, Ernest Chemist will be able to take international contracts which will translate into having very affordable medicines with international standards on the Ghanaian market’

Share.

About Author

Leave A Reply